Introduced by Sen. Jim Ananich (D) on September 15, 2021
To require the Medicaid managed care organizations contracted by the state to operate this program to adopt and provide various “sickle cell disease care management and care” practices. Among other things these would have to “develop a sickle cell disease-focused comprehensive assessment tool to screen for comorbidities…including disease-modifying medications and pain management, psychosocial history, barriers to accessing or completing treatments, social supports, other care coordinators working with the member, community resources being used or needed, quality of life, and personal preferences for engagement with a care coordinator”. Official Text and Analysis.
Referred to the Senate Health Policy and Human Services Committee on September 15, 2021
Reported in the Senate on June 23, 2022
With the recommendation that the substitute (S-3) be adopted and that the bill then pass.